These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 34658364)

  • 1. Developmental role of PHD2 in the pathogenesis of pseudohypoxic pheochromocytoma.
    Eckardt L; Prange-Barczynska M; Hodson EJ; Fielding JW; Cheng X; Lima JDCC; Kurlekar S; Douglas G; Ratcliffe PJ; Bishop T
    Endocr Relat Cancer; 2021 Oct; 28(12):757-772. PubMed ID: 34658364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Research resource: Transcriptional profiling reveals different pseudohypoxic signatures in SDHB and VHL-related pheochromocytomas.
    López-Jiménez E; Gómez-López G; Leandro-García LJ; Muñoz I; Schiavi F; Montero-Conde C; de Cubas AA; Ramires R; Landa I; Leskelä S; Maliszewska A; Inglada-Pérez L; de la Vega L; Rodríguez-Antona C; Letón R; Bernal C; de Campos JM; Diez-Tascón C; Fraga MF; Boullosa C; Pisano DG; Opocher G; Robledo M; Cascón A
    Mol Endocrinol; 2010 Dec; 24(12):2382-91. PubMed ID: 20980436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of ventilatory sensitivity and carotid body proliferation in hypoxia by the PHD2/HIF-2 pathway.
    Hodson EJ; Nicholls LG; Turner PJ; Llyr R; Fielding JW; Douglas G; Ratnayaka I; Robbins PA; Pugh CW; Buckler KJ; Ratcliffe PJ; Bishop T
    J Physiol; 2016 Mar; 594(5):1179-95. PubMed ID: 26337139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germ-line PHD1 and PHD2 mutations detected in patients with pheochromocytoma/paraganglioma-polycythemia.
    Yang C; Zhuang Z; Fliedner SM; Shankavaram U; Sun MG; Bullova P; Zhu R; Elkahloun AG; Kourlas PJ; Merino M; Kebebew E; Pacak K
    J Mol Med (Berl); 2015 Jan; 93(1):93-104. PubMed ID: 25263965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia-Inducible Factor 2α Mutation-Related Paragangliomas Classify as Discrete Pseudohypoxic Subcluster.
    Fliedner SM; Shankavaram U; Marzouca G; Elkahloun A; Jochmanova I; Daerr R; Linehan WM; Timmers H; Tischler AS; Papaspyrou K; Brieger J; de Krijger R; Breza J; Eisenhofer G; Zhuang Z; Lehnert H; Pacak K
    Neoplasia; 2016 Sep; 18(9):567-76. PubMed ID: 27659016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloid PHD2 deficiency accelerates neointima formation via Hif-1α.
    Christoph M; Pfluecke C; Mensch M; Augstein A; Jellinghaus S; Ende G; Mierke J; Franke K; Wielockx B; Ibrahim K; Poitz DM
    Mol Immunol; 2022 Sep; 149():48-58. PubMed ID: 35724581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of HIF-1alpha, HIF-2alpha (EPAS1), and their target genes in paraganglioma and pheochromocytoma with VHL and SDH mutations.
    Pollard PJ; El-Bahrawy M; Poulsom R; Elia G; Killick P; Kelly G; Hunt T; Jeffery R; Seedhar P; Barwell J; Latif F; Gleeson MJ; Hodgson SV; Stamp GW; Tomlinson IP; Maher ER
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4593-8. PubMed ID: 16954163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial PHD2 deficiency induces apoptosis resistance and inflammation via AKT activation and AIP1 loss independent of HIF2α.
    Wang S; Awad KS; Chen LY; Siddique MAH; Ferreyra GA; Wang CL; Joseph T; Yu ZX; Takeda K; Demirkale CY; Zhao YY; Elinoff JM; Danner RL
    Am J Physiol Lung Cell Mol Physiol; 2024 Oct; 327(4):L503-L519. PubMed ID: 39159362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial prolyl hydroxylase 2 is necessary for angiotensin II-mediated renal fibrosis and injury.
    Zhao Y; Zeng H; Liu B; He X; Chen JX
    Am J Physiol Renal Physiol; 2020 Aug; 319(2):F345-F357. PubMed ID: 32715763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of prolyl hydroxylases (PHDs) is selectively controlled by HIF-1 and HIF-2 proteins in nucleus pulposus cells of the intervertebral disc: distinct roles of PHD2 and PHD3 proteins in controlling HIF-1α activity in hypoxia.
    Fujita N; Markova D; Anderson DG; Chiba K; Toyama Y; Shapiro IM; Risbud MV
    J Biol Chem; 2012 May; 287(20):16975-86. PubMed ID: 22451659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased prolyl hydroxylase 3 mRNA expression in oncocytomas compared with clear cell renal cell carcinoma.
    Kampantais S; Kounatidis I; Kotoula V; Vakalopoulos I; Gkagkalidis K; Dimitriadis G
    Int J Biol Markers; 2020 Dec; 35(4):80-86. PubMed ID: 33118406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of Endothelial Hypoxia Inducible Factor-Prolyl Hydroxylase 2 Induces Cardiac Hypertrophy and Fibrosis.
    Dai Z; Cheng J; Liu B; Yi D; Feng A; Wang T; An L; Gao C; Wang Y; Zhu MM; Zhang X; Zhao YY
    J Am Heart Assoc; 2021 Nov; 10(22):e022077. PubMed ID: 34743552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing of HIF prolyl-hydroxylase 2 gene in the renal medulla attenuates salt-sensitive hypertension in Dahl S rats.
    Zhu Q; Hu J; Han WQ; Zhang F; Li PL; Wang Z; Li N
    Am J Hypertens; 2014 Jan; 27(1):107-13. PubMed ID: 24190904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia Upregulates Estrogen Receptor β in Pulmonary Artery Endothelial Cells in a HIF-1α-Dependent Manner.
    Frump AL; Selej M; Wood JA; Albrecht M; Yakubov B; Petrache I; Lahm T
    Am J Respir Cell Mol Biol; 2018 Jul; 59(1):114-126. PubMed ID: 29394091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PHD2 inactivation in Type I cells drives HIF-2α-dependent multilineage hyperplasia and the formation of paraganglioma-like carotid bodies.
    Fielding JW; Hodson EJ; Cheng X; Ferguson DJP; Eckardt L; Adam J; Lip P; Maton-Howarth M; Ratnayaka I; Pugh CW; Buckler KJ; Ratcliffe PJ; Bishop T
    J Physiol; 2018 Jun; 596(18):4393-412. PubMed ID: 29917232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The VHL/HIF Axis in the Development and Treatment of Pheochromocytoma/Paraganglioma.
    Peng S; Zhang J; Tan X; Huang Y; Xu J; Silk N; Zhang D; Liu Q; Jiang J
    Front Endocrinol (Lausanne); 2020; 11():586857. PubMed ID: 33329393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tight control of hypoxia-inducible factor-α transient dynamics is essential for cell survival in hypoxia.
    Bagnall J; Leedale J; Taylor SE; Spiller DG; White MR; Sharkey KJ; Bearon RN; Sée V
    J Biol Chem; 2014 Feb; 289(9):5549-64. PubMed ID: 24394419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-inducible factor prolyl-hydroxylase 2 senses high-salt intake to increase hypoxia inducible factor 1alpha levels in the renal medulla.
    Wang Z; Zhu Q; Xia M; Li PL; Hinton SJ; Li N
    Hypertension; 2010 May; 55(5):1129-36. PubMed ID: 20308610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolyl hydroxylase domain 2 deficiency promotes skeletal muscle fiber-type transition via a calcineurin/NFATc1-dependent pathway.
    Shin J; Nunomiya A; Kitajima Y; Dan T; Miyata T; Nagatomi R
    Skelet Muscle; 2016; 6():5. PubMed ID: 26949511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermediary metabolite precursor dimethyl-2-ketoglutarate stabilizes hypoxia-inducible factor-1α by inhibiting prolyl-4-hydroxylase PHD2.
    Hou P; Kuo CY; Cheng CT; Liou JP; Ann DK; Chen Q
    PLoS One; 2014; 9(11):e113865. PubMed ID: 25420025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.